German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...

The German company said booming artificial-intelligence demand would help its electronics sales grow faster than previously ...

Merck KGaA lowered its medium-term outlook for its healthcare and life-science segment due to China challenges and recent ...

German science and technology company Merck lowered mid-term targets for its Life Sciences and Healthcare businesses, ...

Belen Garijo, the CEO of Merck KGaA, says focus on growth and innovation is key to the German group’s future.

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

Merck's (MRK) monoclonal antibody clesrovimab shows cuts RSV infections by 60% in infants, with a strong safety profile. Read ...

Merck & Co., Inc. (MRK) announced the positive results from the Phase 2b/3 clinical trial (MK-1654-004) evaluating clesrovimab, the ...

German science and technology giant Merck on Thursday said it is confident of returning to medium-term growth after a ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Clesrovimab scored on several endpoints, showing an ability to protect infants against the virus in their first RSV season.

Ken Frazier and Ken Chenault said companies retreating from DEI will limit equal opportunities for disadvantaged Americans.